|Mr. Nicholas Woolf||Chief Exec. Officer||N/A||N/A||1968|
|Mr. Quentin Heath Megson A.C.A., B.Com.||CFO & Joint Company Sec.||N/A||N/A||1971|
|Ms. Sheena Emslie||Chief Operating Officer||N/A||N/A||N/A|
|Dr. Marc Russo||Chief Medical Advisor||N/A||N/A||N/A|
|Ms. Susan Patricia Hunter A.C.A., B.Com., BCom, F Fin, ACA, AGIA, FFin, GAIC||Joint Company Sec.||N/A||N/A||1975|
AusCann Group Holdings Ltd, a pharmaceutical company, researches, develops, cultivates, produces, and distributes cannabinoid-based pharmaceuticals in Australia and internationally. It offers hard-shell capsules using Neuvis technology for the treatment of chronic neuropathic pain. The company is based in West Perth, Australia.
AusCann Group Holdings Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.